Felix Distelmaier

ORCID: 0000-0003-4304-7848
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • Metabolism and Genetic Disorders
  • ATP Synthase and ATPases Research
  • Genomics and Rare Diseases
  • RNA modifications and cancer
  • Genetics and Neurodevelopmental Disorders
  • Coenzyme Q10 studies and effects
  • Biochemical and Molecular Research
  • Cerebral Venous Sinus Thrombosis
  • Biochemical Acid Research Studies
  • Neonatal Health and Biochemistry
  • Diet and metabolism studies
  • Neurosurgical Procedures and Complications
  • Genetics, Aging, and Longevity in Model Organisms
  • RNA Research and Splicing
  • Advanced battery technologies research
  • DNA Repair Mechanisms
  • Blood disorders and treatments
  • RNA regulation and disease
  • Cellular transport and secretion
  • Epilepsy research and treatment
  • Alcoholism and Thiamine Deficiency
  • RNA and protein synthesis mechanisms
  • Genetic Neurodegenerative Diseases
  • Metalloenzymes and iron-sulfur proteins

Heinrich Heine University Düsseldorf
2015-2024

Düsseldorf University Hospital
2015-2024

German Center for Pediatric and Adolescent Rheumatology
2024

Innsbruck Medical University
2023

Universität Innsbruck
2023

Radboud University Nijmegen
2007-2022

Radboud University Medical Center
2007-2022

Radboud Institute for Molecular Life Sciences
2022

Children's Clinical University Hospital
2013-2020

Ludwig-Maximilians-Universität München
2020

Abstract Across a variety of Mendelian disorders, ∼50–75% patients do not receive genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome principle reveals all variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power transcriptome to molecularly diagnose 10% (5 48) mitochondriopathy identify candidate genes for remainder. We find median one aberrantly expressed gene, five...

10.1038/ncomms15824 article EN cc-by Nature Communications 2017-06-12
Michael Zech Robert Jech Sylvia Boesch Matěj Škorvánek Sandrina Weber and 95 more Matias Wagner Chen Zhao Angela Jochim Ján Necpál Yasemin Dincer Katharina Vill Felix Distelmaier Malgorzata Stoklosa Martin Krenn Stephan Grunwald Tobias Bock-Bierbaum Anna Fečíková Petra Havránková Jan Roth Iva Příhodová Miriam Adamovičová Olga Ulmanová Karel Bechyně Pavlína Danhofer Branislav Veselý Vladimír Haň Petra Pavelekova Zuzana Gdovinová Tobias Mantel Tobias Meindl Alexandra Sitzberger Sebastian Schröder Astrid Blaschek Timo Roser Michaela Bonfert Edda Haberlandt Barbara Plecko Birgit Leineweber Steffen Berweck T. Herberhold Berthold Langguth Jana Švantnerová Michal Minár Gonzalo Alonso Ramos-Rivera Monica H. Wojcik Sander Pajusalu Katrin Õunap Ulrich A. Schatz Laura Pölsler Ivan Milenković Franco Laccone Veronika Pilshofer Roberto Colombo Steffi Patzer Arcangela Iuso Julia Vera Mónica Troncoso Fang Fang Holger Prokisch Friederike Wilbert Matthias Eckenweiler Elisabeth Graf Dominik S. Westphal Korbinian M. Riedhammer Theresa Brunet Bader Alhaddad Riccardo Berutti Tim M. Strom Martin Hecht Matthias Baumann Marc E. Wolf Aida Telegrafi Richard Person Francisca Millan Zamora Lindsay B. Henderson David Weise Thomas Musacchio Jens Volkmann Anna Szuto Jessica Becker Kirsten Cremer Thomas Sycha Fritz Zimprich Verena Kraus Christine Makowski Pedro Gonzalez‐Alegre Tanya Bardakjian Laurie J. Ozelius Annalisa Vetro Renzo Guerrini Esther M. Maier Ingo Borggraefe Alice Kuster Saskia B. Wortmann Annette Hackenberg Robert Steinfeld Birgit Assmann Christian Staufner Thomas Opladen Evžen Růžička

10.1016/s1474-4422(20)30312-4 article EN The Lancet Neurology 2020-10-21

Abstract Background Lack of functional evidence hampers variant interpretation, leaving a large proportion individuals with suspected Mendelian disorder without genetic diagnosis after whole genome or exome sequencing (WES). Research studies advocate to further sequence transcriptomes directly and systematically probe gene expression defects. However, collection additional biopsies establishment lab workflows, analytical pipelines, defined concepts in clinical interpretation aberrant are...

10.1186/s13073-022-01019-9 article EN cc-by Genome Medicine 2022-04-04

Acute liver failure (ALF) in infancy and childhood is a life-threatening emergency. Few conditions are known to cause recurrent acute (RALF), about 50% of cases, the underlying molecular remains unresolved. Exome sequencing five unrelated individuals with fever-dependent RALF revealed biallelic mutations NBAS. Subsequent Sanger NBAS 15 additional or ALF identified compound heterozygous an six from families. Immunoblot analysis mutant fibroblasts showed reduced protein levels its proposed...

10.1016/j.ajhg.2015.05.009 article EN cc-by The American Journal of Human Genetics 2015-06-13

Unexplained global developmental delay and epilepsy in childhood pose a major socioeconomic burden. Progress defining the molecular bases does not often translate into effective treatment. Notable exceptions include certain inborn errors of metabolism amenable to dietary intervention. CAD encodes multifunctional enzyme involved de novo pyrimidine biosynthesis. Alternatively, pyrimidines can be recycled from uridine. Exome sequencing three families identified biallelic mutations four children...

10.1093/brain/aww300 article EN Brain 2016-10-31

Abstract Thioredoxin 2 (TXN2; also known as Trx2) is a small mitochondrial redox protein essential for the control of reactive oxygen species homeostasis, apoptosis regulation and cell viability. Exome sequencing in 16-year-old adolescent suffering from an infantile-onset neurodegenerative disorder with severe cerebellar atrophy, epilepsy, dystonia, optic peripheral neuropathy, uncovered homozygous stop mutation TXN2. Analysis patient-derived fibroblasts demonstrated absence TXN2 protein,...

10.1093/brain/awv350 article EN Brain 2015-12-01

To delineate the phenotypic and genotypic spectrum in carriers of mitochondrial MT-ATP6 mutations a large international cohort.We analyzed detail clinical, genetical, neuroimaging data from 132 mutation national registries local databases Europe, USA, Japan, China.We identified 113 clinically affected 19 asymptomatic individuals with known pathogenic mutation. The most frequent were m.8993 T > G (53/132, 40%), C (30/132, 23%), m.9176 m.9185 (12/132, 9%). degree heteroplasmy was high both...

10.1212/nxg.0000000000000393 article EN Neurology Genetics 2020-01-14

Up to 40% of neurodevelopmental disorders (NDDs) such as intellectual disability, developmental delay, autism spectrum disorder, and motor abnormalities have a documented underlying monogenic defect, primarily due de novo variants. Still, the overall burden variants well novel disease genes in NDDs await discovery. We performed parent-offspring trio exome sequencing 231 individuals with NDDs. Phenotypes were compiled using human phenotype ontology terms. The diagnostic yield was 49.8% (n =...

10.1111/cge.13946 article EN cc-by Clinical Genetics 2021-02-23

Coenzyme Q (CoQ) is a key component of the mitochondrial respiratory chain, but it also has several other functions in cellular metabolism. One them to function as an electron carrier reaction catalyzed by sulfide:quinone oxidoreductase (SQR), which catalyzes first hydrogen sulfide oxidation pathway. Therefore, SQR may be affected CoQ deficiency. Using human skin fibroblasts and two mouse models with primary deficiency, we demonstrate that severe deficiency causes reduction levels activity,...

10.15252/emmm.201606345 article EN cc-by EMBO Molecular Medicine 2016-11-17

COA6/C1ORF31 is involved in cytochrome c oxidase (complex IV) biogenesis. We present a new pathogenic COA6 variant detected patient with neonatal hypertrophic cardiomyopathy and isolated complex IV deficiency. For the first time, clinical details about COA6-deficient are given fibroblasts functionally characterized: protein undetectable steady-state levels of several its subunits reduced. The monomeric COX1 assembly intermediate accumulates. Using pulse-chase experiments, we demonstrate an...

10.1002/humu.22715 article EN Human Mutation 2014-10-22

To foster trial-readiness of coenzyme Q8A (COQ8A)-ataxia, we map the clinicogenetic, molecular, and neuroimaging spectrum COQ8A-ataxia in a large worldwide cohort, provide first progression data, including treatment response to Q10 (CoQ10).Cross-modal analysis multicenter cohort 59 COQ8A patients, genotype-phenotype correlations, 3D-protein modeling, vitro mutation analyses, magnetic resonance imaging (MRI) markers, disease progression, CoQ10 data.Fifty-nine patients (39 novel) with 44...

10.1002/ana.25751 article EN Annals of Neurology 2020-04-27

Mitochondrial membrane potential (Deltapsi) is key to mitochondrial function and cellular survival. Here, we aimed develop an automated protocol allowing sensitive quantification of Deltapsi in living cells at the level individual mitochondria. Human skin fibroblasts were stained with fluorescent cation tetramethyl rhodamine methyl ester (TMRM), which sequestered by mitochondria according their Deltapsi. Cells visualized videomicroscopy acquired images processed generate a...

10.1002/cyto.a.20503 article EN Cytometry Part A 2007-12-28

Malfunction of mitochondrial complex I caused by nuclear gene mutations causes early-onset neurodegenerative diseases. Previous work using cultured fibroblasts complex-I-deficient patients revealed elevated levels reactive oxygen species (ROS) and reductions in both total Ca(2+) content the endoplasmic reticulum (ER(Ca)) bradykinin(Bk)-induced increases cytosolic free ([Ca(2+)](C); [Ca(2+)](M)) ATP ([ATP](C); [ATP](M)) concentration. Here, we determined membrane potential (Delta psi) patient...

10.1007/s00109-009-0452-5 article EN cc-by-nc Journal of Molecular Medicine 2009-03-02

Aims: Cell regulation by signaling reactive oxygen species (sROS) is often incorrectly studied through extracellular oxidant addition. Here, we used the membrane-permeable antioxidant Trolox to examine role of sROS in mitochondrial morphology, oxidative phosphorylation (OXPHOS), and cytosolic calcium (Ca2+) handling healthy human skin fibroblasts. Results Innovation: treatment reduced levels 5-(and-6)-chloromethyl-2′,7′-dichlorodihydro-fluorescein (CM-H2DCF) oxidizing ROS, lowered cellular...

10.1089/ars.2011.4294 article EN Antioxidants and Redox Signaling 2012-05-05
Coming Soon ...